Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M82,809Revenue $M19,616Net Margin (%)11.2Altman Z-Score4.0
Enterprise Value $M86,917EPS $2.2Operating Margin %16.0Piotroski F-Score4
P/E(ttm)36.1Beneish M-Score-2.6Pre-tax Margin (%)13.9Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %-6.0Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow33.7y-y EBITDA Growth Rate %-32.9ROA % (ttm)6.2Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)13.0Less Shares Outstanding y-yY
Payout Ratio %96.0Shares Outstanding M1,110ROIC % (ttm)13.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-05-20Sell190,000$73.431.35view
LILLY ENDOWMENT INC10% Owner 2015-05-15Sell200,000$72.832.18view
LILLY ENDOWMENT INC10% Owner 2015-05-08Sell195,000$73.281.56view
LILLY ENDOWMENT INC10% Owner 2015-05-01Sell200,000$73.091.82view
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.940.65view
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.97-3.31view
Fry Stephen FSVP, HR & Diversity 2015-03-09Sell4,000$69.277.43view
Zakrowski Donald AChief Accounting Officer 2015-02-05Sell374$71.034.77view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-04Sell3,147$69.996.33view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-04Sell11,085$70.086.19view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 

    More From Other Websites
    Lilly Sends Employees to Serve in Vulnerable Communities around the World May 27 2015
    Lilly Sends Employees to Serve in Vulnerable Communities around the World May 27 2015
    8:31 am Eli Lilly: FDA approves Humalog 200 units/mL KwikPen May 27 2015
    U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen® May 27 2015
    Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions May 27 2015
    Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American... May 27 2015
    Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American... May 27 2015
    Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions May 27 2015
    Eli Lilly & Company - ZER Reports May 26 2015
    Startup AdverseEvents makes side effects a factor in the cost of a drug May 22 2015
    Debunking The Five Big Myths About 'Big Pharma' May 19 2015
    Eli Lilly Revenues To Soar Through 2020 On New Drugs Growth May 18 2015
    These Americans Are Rich - Should We Celebrate? May 18 2015
    U.S. FDA warns on newer class of type 2 diabetes drugs May 15 2015
    One of the quietest days of the year on Wall Street... May 15 2015
    IPO Stock Watch: Alder Soars On Migraine Drug Results May 15 2015
    Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog May 15 2015
    U.S. FDA warns on newer class of type 2 diabetes drugs May 15 2015
    U.S. FDA warns on newer class of type 2 diabetes drugs May 15 2015
    Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies May 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK